791 related articles for article (PubMed ID: 29563288)
1. Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.
Zerboni L; Sung P; Lee G; Arvin A
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563288
[TBL] [Abstract][Full Text] [Related]
2. A SCID mouse-human lung xenograft model of varicella-zoster virus infection.
Wang W; Pan D; Fu W; Cai L; Ye J; Liu J; Liu C; Huang X; Lin Y; Xia N; Cheng T; Zhu H
Antiviral Res; 2017 Oct; 146():45-53. PubMed ID: 28827121
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.
Sen N; Che X; Rajamani J; Zerboni L; Sung P; Ptacek J; Arvin AM
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):600-5. PubMed ID: 22190485
[TBL] [Abstract][Full Text] [Related]
4. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
[TBL] [Abstract][Full Text] [Related]
5. Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.
François S; Sen N; Mitton B; Xiao X; Sakamoto KM; Arvin A
J Virol; 2016 Oct; 90(19):8686-97. PubMed ID: 27440893
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.
Ku CC; Zerboni L; Ito H; Graham BS; Wallace M; Arvin AM
J Exp Med; 2004 Oct; 200(7):917-25. PubMed ID: 15452178
[TBL] [Abstract][Full Text] [Related]
7. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
Zerboni L; Reichelt M; Arvin A
Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
[TBL] [Abstract][Full Text] [Related]
8. Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.
Campbell TM; McSharry BP; Steain M; Ashhurst TM; Slobedman B; Abendroth A
PLoS Pathog; 2018 Apr; 14(4):e1006999. PubMed ID: 29709039
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.
Choi EJ; Lee CH; Shin OS
Scand J Immunol; 2015 Oct; 82(4):337-44. PubMed ID: 26072679
[TBL] [Abstract][Full Text] [Related]
10. Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo.
Zerboni L; Arvin A
PLoS Pathog; 2015 Jun; 11(6):e1004989. PubMed ID: 26090802
[TBL] [Abstract][Full Text] [Related]
11. Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.
Sen N; Sung P; Panda A; Arvin AM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089701
[TBL] [Abstract][Full Text] [Related]
12. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.
Wang L; Oliver SL; Sommer M; Rajamani J; Reichelt M; Arvin AM
PLoS Pathog; 2011 Aug; 7(8):e1002157. PubMed ID: 21901090
[TBL] [Abstract][Full Text] [Related]
13. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse.
Besser J; Sommer MH; Zerboni L; Bagowski CP; Ito H; Moffat J; Ku CC; Arvin AM
J Virol; 2003 May; 77(10):5964-74. PubMed ID: 12719588
[TBL] [Abstract][Full Text] [Related]
15. Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.
Vleck SE; Oliver SL; Reichelt M; Rajamani J; Zerboni L; Jones C; Zehnder J; Grose C; Arvin AM
J Virol; 2010 Jan; 84(1):141-52. PubMed ID: 19828615
[TBL] [Abstract][Full Text] [Related]
16. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.
Zerboni L; Arvin A
J Neurovirol; 2011 Dec; 17(6):570-7. PubMed ID: 22161683
[TBL] [Abstract][Full Text] [Related]
17. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.
Berarducci B; Rajamani J; Zerboni L; Che X; Sommer M; Arvin AM
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):282-7. PubMed ID: 19966293
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features of Varicella-Zoster Virus Infection.
Kennedy PGE; Gershon AA
Viruses; 2018 Nov; 10(11):. PubMed ID: 30400213
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
Che X; Zerboni L; Sommer MH; Arvin AM
J Virol; 2006 Apr; 80(7):3238-48. PubMed ID: 16537591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
